Breaking News Instant updates and real-time market news.

NVS

Novartis

$85.40

-0.4 (-0.47%)

05:35
12/19/18
12/19
05:35
12/19/18
05:35

Sandoz enters into commercialization, supply agreement for insulin biosimilars

Sandoz, a Novartis division, announced that it has entered into an agreement to commercialize biosimilar versions of insulins used in patients with type 1 and type 2 diabetes. These medicines are currently in early and clinical stages of development for the European Union, United States and other key territories. The commercialization and supply agreement with Gan & Lee aims at bringing to market biosimilar versions of glargine, lispro and aspart, the three top insulin medicines by sales. Gan & Lee is a leading insulin supplier headquartered in China with more than 20 years' experience in insulins and production capacity with attractive cost of goods sold structures. Under the terms of the agreement, Sandoz will be fully responsible for commercializing these medicines in the EU, U.S., Switzerland, Japan, South Korea, Canada, Australia and New Zealand. Gan & Lee will be responsible for manufacturing and development, with support from Sandoz, and shall adhere to the stringent manufacturing requirements established for Sandoz biosimilars. Other specific terms of the agreement are confidential.

  • 05

    Jan

NVS Novartis
$85.40

-0.4 (-0.47%)

12/18/18
COWN
12/18/18
NO CHANGE
COWN
Outperform
Cowen sees Sandoz deal as reinforcing Tilray's competitive positioning
Tilray's (TLRY) expanded global partnership with Novartis (NVS) division Sandoz can not only help expand its reach with pharmacists, physicians and distributors, it can also help Tilray capture early share in new medical cannabis markets as they come online, Cowen analyst Vivien Azer tells investors in a research note. Further, the analyst believes the partnership also helps legitimize cannabis in international markets, which could help influence countries considering medical cannabis legalization. Azer estimates international will represent 15% of Tilray's revenue in fiscal 2020 and 22% in fiscal 2021. Not only does the deal allow Tilray to expand geographic reach, but also to grow at scale, says Azer. And most notably, the Sandoz deal reinforces Tilray's competitive positioning, adds the analyst, who keeps an Outperform rating on the shares with a $150 price target. The stock in morning trading is up 9%, or $5.98, to $71.87.
12/11/18
JEFF
12/11/18
INITIATION
Target $105
JEFF
Buy
Novartis assumed with a Buy at Jefferies
Jefferies analyst Peter Welford assumed coverage of GNovartis with a Buy rating and $105 price target. The analyst is positive on the European large-cap Pharma space "as it enters a period of sustained earnings momentum."
12/07/18
LEHM
12/07/18
DOWNGRADE
LEHM
Underweight
Novartis downgraded to Underweight from Equal Weight at Barclays
12/07/18
FBCO
12/07/18
INITIATION
Target $6.5
FBCO
Outperform
Progenics initiated with an Outperform at Credit Suisse
Credit Suisse analyst Martin Auster initiated Progenics with an Outperform rating and $6.50 price target. In a research note to investors, Auster says he believes Progenics' royalties and future milestones from Relistor and revenue from Azedra support a core business with an NPV of about $5 per share, and says that as the commercial uptake of Azedra begins to unfold, investor focus is expected to turn to upside opportunities in prostate cancer PSMA-targeting diagnostic and therapeutic approaches. He adds that Novartis' (NVS) recent $2.1B acquisition of Endocyte (ECYT) supports pharma interest and attractive valuations in the space.

TODAY'S FREE FLY STORIES

SNAP

Snap

$13.27

-0.73 (-5.21%)

, FB

Facebook

$184.57

2.3 (1.26%)

13:40
10/23/19
10/23
13:40
10/23/19
13:40
On The Fly
#SocialStocks: Snap earnings beat, Facebook CEO testifies about Libra »

Welcome to…

SNAP

Snap

$13.27

-0.73 (-5.21%)

FB

Facebook

$184.57

2.3 (1.26%)

TWTR

Twitter

$38.30

-0.52 (-1.34%)

GOOG

Alphabet

$1,253.59

10.81 (0.87%)

GOOGL

Alphabet Class A

$1,251.72

10.64 (0.86%)

AMZN

Amazon.com

$1,757.06

-9.01 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 21

    Nov

  • 21

    Nov

ALXN

Alexion

$105.87

6.645 (6.70%)

13:37
10/23/19
10/23
13:37
10/23/19
13:37
Recommendations
Alexion analyst commentary  »

Alexion execution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

13:35
10/23/19
10/23
13:35
10/23/19
13:35
General news
Treasury Action: the market took the good auction results in stride »

Treasury Action: the…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/23/19
10/23
13:17
10/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/23/19
10/23
13:16
10/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,254.75

11.97 (0.96%)

, GOOGL

Alphabet Class A

$1,252.88

11.8 (0.95%)

13:08
10/23/19
10/23
13:08
10/23/19
13:08
Periodicals
Google makes search engine remedy in EU more palatable amid pressure, WSJ says »

Sam Schechner and…

GOOG

Alphabet

$1,254.75

11.97 (0.96%)

GOOGL

Alphabet Class A

$1,252.88

11.8 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

CC

Chemours

$17.16

1.1 (6.85%)

13:05
10/23/19
10/23
13:05
10/23/19
13:05
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

T

AT&T

$37.80

-0.38 (-1.00%)

, NWS

News Corp

$14.23

0.03 (0.21%)

12:50
10/23/19
10/23
12:50
10/23/19
12:50
Periodicals
CNN working on digital news service, Information says »

WarnerMedia's (T)…

T

AT&T

$37.80

-0.38 (-1.00%)

NWS

News Corp

$14.23

0.03 (0.21%)

NWSA

News Corp.

$13.86

0.01 (0.07%)

FB

Facebook

$184.53

2.26 (1.24%)

AAPL

Apple

$242.41

2.44 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 18

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

F

Ford

$9.06

-0.005 (-0.06%)

, GM

General Motors

$36.14

-0.185 (-0.51%)

12:47
10/23/19
10/23
12:47
10/23/19
12:47
Earnings
Fly Intel: What to watch in auto sector earnings reports »

Ford (F) is scheduled to…

F

Ford

$9.06

-0.005 (-0.06%)

GM

General Motors

$36.14

-0.185 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 29

    Oct

HEXO

Hexo

$2.54

-0.05 (-1.93%)

12:45
10/23/19
10/23
12:45
10/23/19
12:45
Hot Stocks
Breaking Hot Stocks news story on Hexo 

Hexo Corp trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

NLY

Annaly Capital

$8.94

0.05 (0.56%)

12:45
10/23/19
10/23
12:45
10/23/19
12:45
Options
Annaly Capital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

INTC

Intel

$51.83

-0.175 (-0.34%)

, SFTBF

SoftBank

$0.00

(0.00%)

12:44
10/23/19
10/23
12:44
10/23/19
12:44
Periodicals
Intel files suit against SoftBank's Fortress over patents, Reuters says »

Intel (INTC) has filed an…

INTC

Intel

$51.83

-0.175 (-0.34%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 20

    Nov

C

Citi

$72.11

0.03 (0.04%)

12:42
10/23/19
10/23
12:42
10/23/19
12:42
Periodicals
Judge says Citi claim against Czech miner OKD is eligible, Reuters says »

A Czech court determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

  • 14

    Jan

ALXN

Alexion

$105.68

6.46 (6.51%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Recommendations
Alexion analyst commentary  »

Piper a buyer of Alexion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

SHI

Sinopec Shanghai

$28.18

-0.44 (-1.54%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40
Upgrade
Sinopec Shanghai rating change  »

Sinopec Shanghai upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:40
10/23/19
10/23
12:40
10/23/19
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

SFTBF

SoftBank

$0.00

(0.00%)

, WE

We Company

$0.00

(0.00%)

12:38
10/23/19
10/23
12:38
10/23/19
12:38
Periodicals
WeWork's Claure tells staff layoffs are in the works, Reuters says »

Marcelo Claure,…

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

, RHHBY

Roche

$0.00

(0.00%)

12:36
10/23/19
10/23
12:36
10/23/19
12:36
Periodicals
Trump to nominate Stephen Hahn as FDA commissioner, WSJ reports »

President Trump intends…

BMY

Bristol-Myers

$53.89

-0.55 (-1.01%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$86.51

-0.32 (-0.37%)

GSK

GlaxoSmithKline

$43.27

0.76 (1.79%)

AZN

AstraZeneca

$44.61

0.69 (1.57%)

SNY

Sanofi

$45.54

0.23 (0.51%)

PFE

Pfizer

$36.63

0.19 (0.52%)

MRK

Merck

$82.39

1.09 (1.34%)

LLY

Eli Lilly

$106.97

-3.03 (-2.75%)

JNJ

Johnson & Johnson

$130.13

0.95 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 11

    Nov

  • 12

    Nov

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HEXO

Hexo

$2.54

-0.05 (-1.93%)

12:32
10/23/19
10/23
12:32
10/23/19
12:32
Syndicate
Hexo announces C$70M private placement of convertible debentures »

Hexo Corp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

CRM

Salesforce

$145.02

2.75 (1.93%)

12:30
10/23/19
10/23
12:30
10/23/19
12:30
Options
Heavy delta short term call buyer in Salesforce »

Heavy delta short term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

DYMEF

DionyMed Brands

$0.00

(0.00%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Hot Stocks
DionyMed Brands receives court application seeking to appoint receiver »

DionyMed Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$785.08

-46.605 (-5.60%)

12:29
10/23/19
10/23
12:29
10/23/19
12:29
Periodicals
Hedgeye sees 30% downside in Chipotle, adds to Best Idea Short List 

Reported by Bloomberg.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BA

Boeing

$340.95

3.5 (1.04%)

, CAT

Caterpillar

$133.30

-0.39 (-0.29%)

12:28
10/23/19
10/23
12:28
10/23/19
12:28
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have been a bit…

BA

Boeing

$340.95

3.5 (1.04%)

CAT

Caterpillar

$133.30

-0.39 (-0.29%)

TXN

Texas Instruments

$120.05

-8.56 (-6.66%)

LLY

Eli Lilly

$106.95

-3.05 (-2.77%)

FB

Facebook

$184.57

2.3 (1.26%)

ADI

Analog Devices

$106.03

-4.88 (-4.40%)

MCHP

Microchip

$93.22

-3.09 (-3.21%)

XLNX

Xilinx

$94.81

-1.2 (-1.25%)

NXPI

NXP Semiconductors

$104.12

-3.62 (-3.36%)

TNK

Teekay Tankers

$2.21

0.22 (11.06%)

WGO

Winnebago

$46.96

4.17 (9.75%)

TMO

Thermo Fisher

$296.86

15.97 (5.69%)

SNAP

Snap

$13.22

-0.78 (-5.57%)

REZI

Resideo

$9.06

-6.11 (-40.28%)

LRN

K12

$20.03

-4.81 (-19.36%)

CMG

Chipotle

$784.15

-47.535 (-5.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 20

    Nov

  • 21

    Nov

  • 02

    Dec

  • 07

    Dec

SPLK

Splunk

$117.82

7.41 (6.71%)

12:25
10/23/19
10/23
12:25
10/23/19
12:25
Options
Splunk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$297.03

16.14 (5.75%)

12:23
10/23/19
10/23
12:23
10/23/19
12:23
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

  • 02

    Dec

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.